Sino Biological/FGFR2蛋白，人，重组（His-Tag）/1/10824-H08H
商品编号：
10824-H08H
品牌：
sinobiological
市场价：
¥0.00
美元价：
0.00
联系Q Q：
3392242852
电话号码：
4000-520-616
电子邮箱：
info@ebiomall.com
商品介绍
FGFR2 Protein, Human, Recombinant (His Tag): Product Information
Purity
> 97 % as determined by SDS-PAGE
Endotoxin
< 1.0="" eu="" per="" μg="" of="" the="" protein="" as="" determined="" by="" the="" lal="">
Activity
Measured by its ability to inhibit FGF acidic dependent proliferation of Balb/c3T3 mouse embryonic fibroblasts. The ED50 for this effect is typically 200-400 ng/mL.
Protein Construction
A DNA sequence encoding the human FGFR2 (NP_000132.3) extracellular domain (Met 1-Glu 377) was expressed, fused with a polyhistidine tag at the C-terminus.
Accession#
NP_000132.3
Expressed Host
HEK293 Cells
Species
Human
Predicted N Terminal
Arg 22
Molecule Mass
The recombinant human FGFR2 consists of 367 amino acids after removal of the signal peptide and has a calculated molecular mass of 41 kDa. In SDS-PAGE under reducing conditions, the apparent molecular mass of rhFGFR2 is approximately 65-75 kDa due to glycosylation.
Formulation
Lyophilized from sterile PBS, pH 7.4Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the hard copy of CoA.
Shipping
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Stability & Storage
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution
A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.
FGFR2 Protein, Human, Recombinant (His Tag): Images
Measured by its ability to inhibit FGF acidic dependent proliferation of Balb/c3T3 mouse embryonic fibroblasts. The ED50 for this effect is typically 200-400 ng/mL.
FGFR2 Protein, Human, Recombinant (His Tag): Synonyms
BBDS Protein, Human; BEK Protein, Human; BFR-1 Protein, Human; CD332 Protein, Human; CEK3 Protein, Human; CFD1 Protein, Human; ECT1 Protein, Human; JWS Protein, Human; K-SAM Protein, Human; KGFR Protein, Human; TK14 Protein, Human; TK25 Protein, Human
FGFR2 Background Information
FGFR2, also known as CD332, belongs to the fibroblast growth factor receptor subfamily where amino acid sequence is highly conserved between members and throughout evolution. FGFR2 acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. It is required for normal embryonic patterning, trophoblast function, limb bud development, lung morphogenesis, osteogenesis and skin development. FGFR2 plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. It also promotes cell proliferation in keratinocytes and imature osteoblasts, but promotes apoptosis in differentiated osteoblasts. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal CD332 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1. Defects in CD3322 are the cause of Crouzon syndrome, Jackson-Weiss syndrome, Apert syndrome, Pfeiffer syndrome, Beare-Stevenson cutis gyrata syndrome, familial scaphocephaly syndrome, lacrimo-auriculo-dento-digital syndrome and Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis.
- Cancer Immunotherapy
- Immune Checkpoint
- Immunotherapy
- Targeted Therapy
Full Name
fibroblast growth factor receptor 2
Research Areas
- Receptor Tyrosine Kinases (RTKs)
- Cancer Drug Targets
References
- Marie PJ, et al. (2003) Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling. Histol. 17(3):877-85.
- Park WJ, et al. (1996) Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability. Hum Mol Genet. 4(7):1229-33.
- Orr-Urtreger A, et al. (1993) Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev Biol. 158(2):475-86.
Human FGFR2 Proteins
- FGFR2 Protein, Human, Recombinant (ECD, His Tag)16485-H08H
- FGFR2 Protein, Human, Recombinant (beta IIIc, His Tag)16483-H08H
- FGFR2 Protein, Human, Recombinant (alpha IIIb, hFc Tag)16485-H02H
- FGFR2 Protein, Human, Recombinant (aa 400-821, His & GST Tag)10824-H20B1
- FGFR2 Protein, Human, Recombinant (His & hFc Tag)10824-H03H
Mouse FGFR2 Proteins
- FGFR2 Protein, Mouse, Recombinant (hFc Tag)51128-M02H
- FGFR2 Protein, Mouse, Recombinant (His Tag)51128-M08H
- Identification and validation of FGFR2 peptide for detection of early Barrett"s neoplasiaAuthorZhou, J;He, L;Pang, Z;Appelman, HD;Kuick, R;Beer, DG;Li, M;Wang, TD;Year2017JournalOncotargetApplicationbinding (biopanning)PubMed ID: 29152066FoldedExpand
- Cordycepin inhibits pancreatic cancer cell growth in vitro and in vivo via targeting FGFR2 and blocking ERK signalingAuthorLi, XY;Tao, H;Jin, C;DU, ZY;Liao, WF;Tang, QJ;Ding, K;Year2020JournalChin J Nat MedPubMed ID: 32451092FoldedExpand
If you couldn"t find the specific citation, you can:
- Find All Citations
- Submit a CitationGet a Publication Reward
- Leave Us a Message
E.coli protein expression service
Mammalian transient protein expression service
Baculovirus-insect expression service
Stable cell line development service (CHO / HEK293)
品牌介绍
北京义翘神州科技股份有限公司（Sino Biological Inc.）是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司，主要业务包括重组蛋白、抗体、基因和培养基等产品，以及重组蛋白、抗体的开发和生物分析检测等服务。义翘神州为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。公司目前生产和销售的现货产品种类超过 4.6 万种，其中重组蛋白约 6,000 种，包括超过 3,800 种人源细胞表达重组蛋白产品，能够全面满足客户对于最接近人体天然蛋白结构和性质的重组蛋白需求；公司还能提供约 12,000 种抗体，其中单克隆抗体数量约 4,600 种，能够覆盖生命科学研究的多个领域，为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供「一站式」生物试剂产品和技术服务。义翘神州的客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲建立了子公司，已成为生物试剂行业国内领先的科技公司之一。
联络我们
